Anastrozole Tablets
Anastrozole is commonly supplied as an oral tablet. Check the labeled amount per tablet and total package quantity on each product listing.
Aromatase Inhibitor (AI)
Browse Anastrozole products and compare labeled tablet strengths, package quantities, manufacturers, published lab reports and current USA Domestic or International Warehouse availability.
Trade Name: Arimidex 2 mg
Compound: Anastrozole
Strength: 2 mg/pill
Container: 100 Pills
Manufacturer: Stealth Labs USA
Lab Tested: View Result
Shipped Without Label!
Aromatase Inhibitor (AI)
The Anastrozole category brings together available products containing this nonsteroidal aromatase inhibitor (AI), also widely associated with the Arimidex name. Browse the current selection and compare labeled tablet strengths, package quantities, manufacturers, published laboratory testing, pricing and USA Domestic or International warehouse availability.
Anastrozole is commonly supplied as an oral tablet. Check the labeled amount per tablet and total package quantity on each product listing.
Products can differ in labeled tablet strength, package quantity and manufacturer even when they contain the same active substance.
Where laboratory reports are available, individual product pages provide access to measured results, testing dates and reported batch information.
Anastrozole products may be stocked in the USA Domestic Warehouse, International Warehouse or both depending on current inventory.
Anastrozole is a nonsteroidal aromatase inhibitor (AI). Aromatase is an enzyme involved in the conversion of androgens into estrogens, and inhibiting this enzyme can substantially reduce estrogen production.
Anastrozole is a prescription medicine with established medical applications, including the treatment of certain hormone receptor-positive breast cancers in postmenopausal women. It is not an anabolic-androgenic steroid and does not belong to the same pharmacological class as testosterone or other anabolic steroids.
Anastrozole identifies the active pharmaceutical ingredient. Arimidex is a well-known brand name associated with Anastrozole, while AI is the commonly used abbreviation for the broader aromatase inhibitor drug class.
Generic and manufacturer-specific Anastrozole products may use different names or packaging. Checking the listed active substance, tablet strength and package quantity provides a more reliable comparison than relying on branding alone.
Aromatase participates in estrogen biosynthesis by converting certain androgen precursors into estrogens. Anastrozole inhibits aromatase activity, thereby reducing estrogen production.
This mechanism is different from simply blocking an estrogen receptor. The distinction is important because reducing estrogen synthesis and interfering with estrogen signaling at a receptor are different pharmacological approaches.
Anastrozole's effects on estrogen are clinically significant, which is also why unnecessary or excessive suppression of estrogen can produce adverse consequences.
Anastrozole should not be confused with selective estrogen receptor modulators (SERMs) such as Tamoxifen or Clomiphene. Although both drug classes involve estrogen-related pathways, their mechanisms are different.
Anastrozole inhibits the aromatase enzyme and therefore reduces estrogen synthesis. SERMs instead interact with estrogen receptors and can act differently depending on the tissue involved.
For product comparison, an aromatase inhibitor and a SERM should therefore not be treated as interchangeable simply because both may appear within the same PCT or ancillary product category.
Anastrozole is one member of the aromatase inhibitor class. Other active substances in this category can include compounds such as Exemestane and Letrozole.
These substances share the broad goal of inhibiting aromatase but are not identical medicines. Their chemical structures, pharmacological characteristics and approved clinical uses can differ.
When comparing AI products, check the actual active substance rather than treating Anastrozole, Exemestane and Letrozole as different brand names for the same drug.
When browsing Anastrozole products, useful comparison points include the labeled amount per tablet, total tablet count, manufacturer, current price, warehouse location and published laboratory testing where available.
Products containing the same active substance can still differ in tablet strength, package quantity and manufacturer-specific specifications. These characteristics should be reviewed separately rather than comparing products by price or branding alone.
The labeled mg-per-tablet strength identifies the amount of Anastrozole stated in each tablet. Package quantity separately identifies the number of tablets supplied.
Two Anastrozole products can therefore contain the same active substance while differing in tablet strength or total package quantity. Check both specifications when comparing available products.
Selected Anastrozole products may have published laboratory reports that provide an additional reference point when comparing the labeled specification with the measured result reported for a submitted sample.
Where testing is available, review the identified active substance, measured result, testing date and reported batch number. If several reports have been published for the same product, results from different testing dates or batches can be reviewed individually.
Each laboratory report applies to the submitted sample identified in that analysis. A result from one sample does not independently verify every tablet, package or subsequent production batch.
Estrogen should not be viewed simply as an unwanted hormone. It contributes to multiple physiological processes, including bone health, lipid metabolism and other aspects of normal endocrine function.
Because Anastrozole can substantially reduce estrogen production, excessive estrogen suppression can itself be undesirable. The goal of medically indicated aromatase inhibition is therefore not equivalent to eliminating estrogen entirely.
Anastrozole is a pharmacologically active prescription medicine and can cause clinically significant adverse effects. Its reduction of estrogen levels can affect several body systems rather than only estrogen-related symptoms.
Potential concerns include effects on bone mineral density, musculoskeletal symptoms and changes in cholesterol. Product-specific warnings, contraindications and drug interactions should also be considered.
The consequences of aromatase inhibition depend on individual hormone status, medical history, other medications and the clinical reason for treatment. Symptoms alone cannot reliably determine whether estrogen is elevated or whether aromatase inhibition is appropriate.
A published laboratory report can provide information about the analyzed product sample but does not establish that taking Anastrozole is medically appropriate for an individual. This category is intended for product identification and comparison and does not provide individualized dosing or hormone-management protocols.
Anastrozole is sometimes discussed in bodybuilding contexts because some anabolic-androgenic steroids can increase estrogen production through aromatization. This is one reason aromatase inhibitors frequently appear alongside anabolic steroid products in performance-oriented catalogs.
However, the presence of an aromatizable steroid does not establish that Anastrozole is required. Estrogen response varies between individuals, and unnecessary aromatase inhibition can result in excessively low estrogen levels and associated adverse effects.
For that reason, this category provides information about the substance and available products rather than recommending Anastrozole doses, steroid-cycle combinations or estrogen-management protocols.
Anastrozole has established medical use as an aromatase inhibitor, particularly in the treatment of certain hormone receptor-positive breast cancers in postmenopausal women.
Clinical use involves medical assessment of the condition being treated, relevant risk factors and appropriate monitoring. The existence of an approved medical use should not be interpreted as making unsupervised use appropriate for unrelated purposes.
Anastrozole products may be available from the USA Domestic Warehouse, the International Warehouse, or both. Available manufacturers, tablet strengths and stock levels can differ between warehouse locations.
For delivery within the United States, USA Domestic shipments typically take 4–5 business days after dispatch, while International Warehouse shipments typically take 15–20 business days after dispatch.
Delivery estimates begin after dispatch and do not include order processing time. Additional delivery, tracking and reship information is available on the Shipping Information page.
Bitcoin and other supported cryptocurrencies are available at checkout. When comparing Anastrozole products, review the manufacturer, labeled tablet strength, package quantity, current price, available laboratory reports and warehouse location.
Where the store's separate crypto discount applies, eligibility depends on the current pricing status of the product. Already discounted products should not automatically be assumed to qualify for an additional discount.